Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.

Clinical trial NCT05145062 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05145062
Sponsor: Sangamo Therapeutics
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Blood and Lymphatic Diseases

Start date: 2021-12-21
Primary completion: 2038-07-14
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.